Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
24,376,802
-
Shares change
-
+1,409,453
-
Total reported value, excl. options
-
$1,072,967,175
-
Value change
-
+$75,631,280
-
Number of buys
-
56
-
Number of sells
-
-43
-
Price
-
$44.01
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q3 2014
116 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q3 2014.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24,376,802 shares
of 80,437,135 outstanding shares and own 30.31% of the company stock.
Largest 10 shareholders include FMR LLC (4,460,377 shares), BROOKSIDE CAPITAL MANAGEMENT LLC (2,862,025 shares), WELLINGTON MANAGEMENT CO LLP (2,333,256 shares), CREDIT SUISSE AG/ (1,562,810 shares), Sectoral Asset Management Inc (1,322,398 shares), BlackRock Fund Advisors (897,814 shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (879,602 shares), State Street Corp (821,814 shares), WESTFIELD CAPITAL MANAGEMENT CO LP (720,980 shares), and PERCEPTIVE ADVISORS LLC (671,736 shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.